{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-005124","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.098117+00:00","generated_at":"2026-06-18T22:21:17.621954+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Fulgent Genetics Q4 2022 GAAP loss $0.80/share; core revenue up 97% YoY to $55M","bullets":["Q4 total revenue $67.7M; core revenue (ex-COVID) $55.0M, up 97% YoY.","GAAP net loss $23.8M ($0.80 per share); non-GAAP loss $14.2M ($0.48 per share).","Full year 2022 core revenue $181.5M, up 95% YoY; total revenue $619.0M.","Cash and investments $872.0M as of Dec 31, 2022; repurchased 815k shares in Q4.","Full year GAAP net income $143.4M ($4.63 per share); adjusted EBITDA $257.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-005124","json":"https://secwatch.observer/filing/0000950170-23-005124.json","markdown":"https://secwatch.observer/filing/0000950170-23-005124.md","text":"https://secwatch.observer/filing/0000950170-23-005124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017023005124/0000950170-23-005124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017023005124/flgt-20230228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T22:21:17.621954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7f873e0de8a1d2c308d930fd051b2923318eb248","claim":"Fulgent Genetics, Inc. reported the fiscal quarter and year ended December 31, 2022 results: revenue $619.0 million, net income GAAP income of $143.4 million, EPS $4.63 per share.","evidence_excerpt":"Current Report on Form 8-K. --- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results • Full Year 2022 Total Revenue of $619.0 million; Q4 Total Revenue of $67.7 million • Full Year 2022 Core Revenue grows 95% year-over-year to $181.5 million; Q4 Core Revenue grows 97% year-over-year to $55.0 million TEMPLE","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017023005124/0000950170-23-005124-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter and year ended December 31, 2022"},{"label":"Revenue","value":"$619.0 million"},{"label":"Net income","value":"GAAP income of $143.4 million"},{"label":"EPS","value":"$4.63 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}